Biggest News Aggregation in the World
📰 Derived Cell News

Derived Cell News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Derived Cell. Real-time updates on events, politics, business and more.

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

PHILADELPHIA, April 08, 2024 -- Century Therapeutics , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology and autoimmune and...
United States Julie Seidel Noor Exchange Commission Derived Cell Board Number Adoptive Cell Therapies

Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Vast Potential in Cell Therapy, Disease Modelling, Drug Development and Discovery, Personalized Medicine & Toxicology Testing

/PRNewswire/ -- The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report, 2022" report has been added to ResearchAndMarkets.coms offering. Since the...
Cellgenix Gmb Catalent Biologics Laura Wood Research Publications Research Within The Overall Stem Cell Industry Alstem Inc

Global Induced Pluripotent Stem Cell (iPS Cell) Industry

Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand April 13, 2021 06:13 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. The main objectives of this report are to describe the current status of iPSC research, patents, funding events, industry partnerships, biomedical applications, technologies, and clinical tr...
United States James Thomson Takara Bio Biocat Gmb Waisman Biomanufacturing Cellgenix Gmb

Global Induced Pluripotent Stem Cell (iPS Cell) Market Report 2021: In Total, At Least 68 Distinct Market Competitors Now Offer Various Types of iPSC Products, Services, Technologies and Therapies

Share this article Share this article ResearchAndMarkets.coms offering. The main objectives of this report are to describe the current status of iPSC research, patents, funding events, industry partnerships, biomedical applications, technologies, and clinical trials for the development of iPSC-based therapeutics. Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research product market has grown into existence, largely because the cells are non-controversial and...
United States James Thomson Takara Bio Biocat Gmb Waisman Biomanufacturing Cellgenix Gmb

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science